Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment
<p>Abstract</p> <p>Background</p> <p>Botulinum Toxin Type-A (BoNT/A) intraprostatic injection can induce prostatic involution and improve LUTS and urinary flow in patients with Benign Prostatic Enlargement (BPE). However, the duration of these effects is unknown. The ob...
Main Authors: | Oliveira Rui, Silva Pedro, Botelho Francisco, Carvalho Tiago, Pinto Rui, Silva João, Silva Carlos, Cruz Francisco, Dinis Paulo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-08-01
|
Series: | BMC Urology |
Online Access: | http://www.biomedcentral.com/1471-2490/9/9 |
Similar Items
-
Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
by: Yu-Chao Hsu, et al.
Published: (2016-04-01) -
Detrusor contraction duration and strength in the patients with benign prostatic enlargement
by: Damir Aganovic, et al.
Published: (2004-02-01) -
Lysozyme gene treatment in testosterone induced benign prostate hyperplasia rat model and comparasion of its’ effectiveness with botulinum toxin injection
by: Osman Ergün, et al. -
Ultrasound-guided botulinum toxin injections
by: S. E. Khatkova, et al.
Published: (2016-07-01) -
Effect of Intratrigonal Botulinum Toxin in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Long-Term, Single-Center Study in Real-Life Conditions
by: Pedro Abreu-Mendes, et al.
Published: (2022-11-01)